Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Insite Vision Inc. -- Ignore unavailable to you. Want to Upgrade?

To: jbershad who wrote (812)	8/6/1998 10:56:00 AM
From: Awashonks	Read Replies (3) \| Respond to of 1060

New from Michael Murphy's Wednesday hotline update. The consultant he hired to research ISV's deal came back with a report. The company they are in final negotiations with doesn't want to pay more than $4/5 share for the whole company, so ISV won't sell (unless they get closer to $10). The company wants to actually see the test kit and (see it work?) before they invest in the big partnership. (Can you imagine?) Murphy understood that the kit is done (he's confirming this again) and so he believes the deal is imminent. This explains the stock's drop yesterday and today. It sounds like the deal is on and happening soon. (We've heard that before...) Good luck. Awashonks P.S. If anyone has an additional take on the hotline info please post...